Contrarius Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Contrarius Investment Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$36.8M	Buy
2024 Q2	$37M	Buy
2024 Q1	$45.4M	Buy
2023 Q4	$11.5M	Sell
2023 Q3	$10M	Sell
2023 Q2	$12.9M	Buy